MoneyWorks4Me

Procter & Gamble Health informs about corporate action

06 Feb 2024 Evaluate
Procter & Gamble Health has informed that the Board has approved interim dividend for Financial Year 2023-24 at its meeting held today. It has enclosed details regarding record date and payout of said dividend.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..